Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The effectiveness of real-time continuous glucose monitoring (rtCGM) in avoidance
of hypoglycaemia among high-risk individuals with type 1 diabetes treated with multiple
daily insulin injections (MDI) is unknown. We aimed to ascertain whether the incidence
and severity of hypoglycaemia can be reduced through use of rtCGM in these individuals.